Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Sippl

Showing results (1-10 of 310) with videos related to

Pageof 31
Sort By:
International Journal of Molecular Sciences|April 13, 2023
Editorial for Special Issue-"Early-Stage Drug Discovery: Advances and Challenges"Wolfgang Sippl
Journal of Computer-Aided Molecular Design|June 27, 2003
Development of biologically active compounds by combining 3D QSAR and structure-based design methodsWolfgang Sippl
Bioorganic & Medicinal Chemistry|November 5, 2002
Binding affinity prediction of novel estrogen receptor ligands using receptor-based 3-D QSAR methodsWolfgang Sippl
The FEBS Journal|December 4, 2010
Activation, regulation, and inhibition of DYRK1AWalter Becker, Wolfgang Sippl
Bioorganic & Medicinal Chemistry|June 14, 2011
Epigenetic drug discovery special issueWolfgang Sippl, Manfred Jung
European Journal of Medicinal Chemistry|March 10, 2015
Docking and binding free energy calculations of sirtuin inhibitorsBerin Karaman, Wolfgang Sippl
Pharmazie in Unserer Zeit|April 29, 2010
[Development of histone deacetylase inhibitors Potent active ingredients especially in cancer]Ralf Heinke, Wolfgang Sippl
Current Medicinal Chemistry|June 1, 2018
Computational Drug Repurposing: Current TrendsBerin Karaman, Wolfgang Sippl
Frontiers in Chemistry|August 16, 2021
Editorial: Application of PROTACs as a Novel Strategy for Drug DiscoveryHany S Ibrahim, Wolfgang Sippl
Molecules (Basel, Switzerland)|January 9, 2021
Editorial to Special Issue-"Structure-Activity Relationships (SAR) of Natural Products"Wolfgang Sippl, Fidele Ntie-Kang
Pageof 31

Showing results (1-10 of 310) with videos related to

Sort By:
Pageof 31
International Journal of Molecular Sciences|April 13, 2023
Editorial for Special Issue-"Early-Stage Drug Discovery: Advances and Challenges"Wolfgang Sippl
Journal of Computer-Aided Molecular Design|June 27, 2003
Development of biologically active compounds by combining 3D QSAR and structure-based design methodsWolfgang Sippl
Bioorganic & Medicinal Chemistry|November 5, 2002
Binding affinity prediction of novel estrogen receptor ligands using receptor-based 3-D QSAR methodsWolfgang Sippl
The FEBS Journal|December 4, 2010
Activation, regulation, and inhibition of DYRK1AWalter Becker, Wolfgang Sippl
Bioorganic & Medicinal Chemistry|June 14, 2011
Epigenetic drug discovery special issueWolfgang Sippl, Manfred Jung
European Journal of Medicinal Chemistry|March 10, 2015
Docking and binding free energy calculations of sirtuin inhibitorsBerin Karaman, Wolfgang Sippl
Pharmazie in Unserer Zeit|April 29, 2010
[Development of histone deacetylase inhibitors Potent active ingredients especially in cancer]Ralf Heinke, Wolfgang Sippl
Current Medicinal Chemistry|June 1, 2018
Computational Drug Repurposing: Current TrendsBerin Karaman, Wolfgang Sippl
Frontiers in Chemistry|August 16, 2021
Editorial: Application of PROTACs as a Novel Strategy for Drug DiscoveryHany S Ibrahim, Wolfgang Sippl
Molecules (Basel, Switzerland)|January 9, 2021
Editorial to Special Issue-"Structure-Activity Relationships (SAR) of Natural Products"Wolfgang Sippl, Fidele Ntie-Kang
Pageof 31